0000891293-15-000058.txt : 20151110 0000891293-15-000058.hdr.sgml : 20151110 20151106180844 ACCESSION NUMBER: 0000891293-15-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151104 FILED AS OF DATE: 20151106 DATE AS OF CHANGE: 20151106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plunkett Matthew CENTRAL INDEX KEY: 0001557551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151213548 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-11-04 0 0000891293 CTI BIOPHARMA CORP ctic 0001557551 Plunkett Matthew 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Corporate Development Common Stock 2015-11-04 4 S 0 1900 1.37 D 638184 D Common Stock 2015-11-04 4 S 0 1800 1.375 D 636384 D Common Stock 2015-11-04 4 S 0 3500 1.38 D 632884 D Common Stock 2015-11-04 4 S 0 200 1.385 D 632684 D Common Stock 2015-11-04 4 S 0 1100 1.39 D 631584 D Common Stock 2015-11-04 4 S 0 100 1.395 D 631484 D Common Stock 2015-11-04 4 S 0 1400 1.4 D 630084 D This sale was effected pursuant to a Rule 10b5-1 trading plan. By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett 2015-11-06